The World Marrow Donor Association (WMDA) has posted a position paper discussing how to handle facility confidentiality when labeling Cellular  Therapy products from unrelated donors. 

In this paper the "WMDA encourages the efforts to adapt ISBT 128 as an effective bar-coded information coding system that supports a globally unique identity,standardized product coding and full traceability of cellular therapy products."

See the position paper here:

http://www.wbmt.org/fileadmin/pdf/01_General/WBMT_position_statement_for_European_Labeling_and_ISBT.pdf

 12 August 2011